These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18946201)

  • 1. Creation of a tool to assess adherence to treatments for acne.
    Pawin H; Beylot C; Chivot M; Faure M; Poli F; Revuz J; Dréno B
    Dermatology; 2009; 218(1):26-32. PubMed ID: 18946201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale worldwide observational study of adherence with acne therapy.
    Dréno B; Thiboutot D; Gollnick H; Finlay AY; Layton A; Leyden JJ; Leutenegger E; Perez M;
    Int J Dermatol; 2010 Apr; 49(4):448-56. PubMed ID: 20465705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective assessment of compliance with treatments in acne.
    Zaghloul SS; Cunliffe WJ; Goodfield MJ
    Br J Dermatol; 2005 May; 152(5):1015-21. PubMed ID: 15888162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris.
    Matsuoka Y; Yoneda K; Sadahira C; Katsuura J; Moriue T; Kubota Y
    J Dermatol; 2006 Nov; 33(11):745-52. PubMed ID: 17073988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
    Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
    Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermabrasion for acne scars during treatment with oral isotretinoin.
    Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
    Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
    Kaymak Y; Taner E; Taner Y
    Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acne management in Japan: study of patient adherence.
    Miyachi Y; Hayashi N; Furukawa F; Akamatsu H; Matsunaga K; Watanabe S; Kawashima M
    Dermatology; 2011; 223(2):174-81. PubMed ID: 22025005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort.
    Cohen J; Adams S; Patten S
    Can J Clin Pharmacol; 2007; 14(2):e227-33. PubMed ID: 17556790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective assessment of compliance with psoriasis treatment.
    Zaghloul SS; Goodfield MJ
    Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Azoulay L; Oraichi D; Bérard A
    Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acne].
    Jemec GB
    Ugeskr Laeger; 2000 Dec; 162(50):6840-4. PubMed ID: 11187138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach for the use of oral isotretinoin for infantile acne.
    Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
    Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported adherence to treatment and quality of life in mild to moderate acne.
    Jones-Caballero M; Pedrosa E; Peñas PF
    Dermatology; 2008; 217(4):309-14. PubMed ID: 18714158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.